Vitiligo Update: Focus on Melanocyte–Keratinocyte Transplantation with Dr. Bassel Mahmoud
In this episode of Skinscope, Dr. Bassel Mahmoud https://www.instagram.com/drbasselmahmoud/ explores vitiligo as a complex autoimmune skin disorder characterized by the destruction of melanocytes. He discusses the genetic basis of the disease, its clinical subtypes, diagnostic tools, and the significant psychological and cultural stigma experienced by many patients.The episode provides a comprehensive overview of current vitiligo treatment strategies, ranging from topical and systemic therapies to advanced surgical interventions, with a special focus on melanocyte–keratinocyte transplantation (MKTP). Dr. Mahmoud emphasizes the importance of disease stability, careful patient selection, and realistic expectations in achieving successful surgical outcomes.Emerging therapies—including JAK inhibitors—are reviewed alongside supportive options such as cosmetic camouflage and tattooing for patients with limited therapeutic choices. The episode concludes with insights into ongoing research and future directions in vitiligo management, as well as Dr. Mahmoud’s academic contributions to the field, including his contributions to the Springer reference Updates in Vitiligo https://link.springer.com/book/10.1007/978-3-032-05928-4, a key resource for clinicians and researchers.Dr. Sandra Jerkovic Gulin (https://www.instagram.com/skindoc_sandra_jg/) & Dr. George Kravvas (https://www.instagram.com/drgeorgekravvas/)https://drkravvasdermatology.co.uk/Key TakeawaysVitiligo is an autoimmune disease targeting melanocytesGenetic predisposition plays a major role in disease developmentNon-segmental vitiligo is the most common subtypeVitiligo can have a profound psychological and social impactDiagnosis may involve dermoscopy and Wood’s lamp examinationTreatment focuses on limiting immune destruction and restoring pigmentationTopical corticosteroids remain first-line therapyJAK inhibitors are a promising emerging treatmentSurgical interventions are effective for stable, treatment-resistant vitiligoMKTP shows success rates of approximately 75–80% in well-selected patientsProper patient selection is critical for surgical successTeledermatology is now essential for follow-up careCosmetic camouflage can significantly improve quality of lifeTattooing may be considered a last-line option, with long-term color changes requiring cautionOngoing research into vitiligo pathogenesis is key to future therapiesEpisode ChaptersIntroduction to vitiligo and clinical overviewCauses, genetics, and disease subtypesDiagnosis, stigma, and psychosocial considerationsMedical management of vitiligoEmerging therapies and access challengesSurgical management and MKTPRepigmentation, follow-up, and teledermatologyCamouflage, tattooing, and quality of lifeFuture directions and academic insightsSEOvitiligo, vitiligo update, dermatology podcast, autoimmune skin disease, melanocytes, pigmentation disorders, non-segmental vitiligo, genetics, psychological impact, stigma, vitiligo diagnosis, Wood’s lamp, dermoscopy, topical steroids, JAK inhibitors, vitiligo surgery, melanocyte keratinocyte transplantation, MKTP, repigmentation, teledermatology, cosmetic camouflage, vitiligo tattoo, emerging dermatology treatments, Updates in Vitiligo, Springer
